Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 17 studies | 28% ± 13% | |
astrocyte | 15 studies | 41% ± 18% | |
macrophage | 13 studies | 27% ± 10% | |
fibroblast | 9 studies | 24% ± 9% | |
adipocyte | 9 studies | 32% ± 7% | |
oligodendrocyte precursor cell | 8 studies | 28% ± 16% | |
myeloid cell | 8 studies | 24% ± 6% | |
epithelial cell | 8 studies | 34% ± 17% | |
glutamatergic neuron | 7 studies | 32% ± 19% | |
oligodendrocyte | 7 studies | 28% ± 10% | |
GABAergic neuron | 6 studies | 30% ± 17% | |
interneuron | 6 studies | 34% ± 20% | |
microglial cell | 6 studies | 33% ± 11% | |
ciliated cell | 6 studies | 25% ± 6% | |
basal cell | 6 studies | 30% ± 16% | |
type II pneumocyte | 6 studies | 22% ± 8% | |
monocyte | 6 studies | 26% ± 7% | |
neuron | 5 studies | 28% ± 14% | |
dendritic cell | 5 studies | 19% ± 3% | |
Mueller cell | 5 studies | 30% ± 13% | |
endothelial cell of lymphatic vessel | 5 studies | 22% ± 5% | |
club cell | 5 studies | 19% ± 5% | |
smooth muscle cell | 5 studies | 19% ± 2% | |
type I pneumocyte | 5 studies | 23% ± 7% | |
classical monocyte | 4 studies | 23% ± 3% | |
granule cell | 4 studies | 21% ± 5% | |
cardiac muscle cell | 4 studies | 20% ± 2% | |
lymphocyte | 4 studies | 22% ± 4% | |
pericyte | 4 studies | 25% ± 8% | |
mesothelial cell | 3 studies | 25% ± 7% | |
retinal rod cell | 3 studies | 22% ± 5% | |
hepatocyte | 3 studies | 35% ± 23% | |
retinal pigment epithelial cell | 3 studies | 32% ± 21% | |
alveolar macrophage | 3 studies | 39% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2823.63 | 1445 / 1445 | 100% | 51.65 | 183 / 183 |
lung | 100% | 4104.18 | 578 / 578 | 100% | 20.87 | 1155 / 1155 |
ovary | 100% | 3337.51 | 180 / 180 | 100% | 14.63 | 430 / 430 |
stomach | 100% | 2138.08 | 359 / 359 | 100% | 16.25 | 286 / 286 |
brain | 100% | 3253.19 | 2640 / 2642 | 100% | 24.34 | 705 / 705 |
intestine | 100% | 3133.78 | 966 / 966 | 100% | 15.07 | 526 / 527 |
prostate | 100% | 2982.35 | 245 / 245 | 100% | 13.38 | 501 / 502 |
breast | 100% | 4173.03 | 459 / 459 | 100% | 27.10 | 1114 / 1118 |
bladder | 100% | 2917.43 | 21 / 21 | 100% | 15.14 | 502 / 504 |
uterus | 100% | 3528.04 | 170 / 170 | 99% | 13.61 | 456 / 459 |
thymus | 100% | 3782.88 | 653 / 653 | 99% | 16.01 | 600 / 605 |
kidney | 100% | 2813.98 | 89 / 89 | 99% | 12.67 | 891 / 901 |
skin | 100% | 3806.68 | 1809 / 1809 | 99% | 21.05 | 466 / 472 |
pancreas | 100% | 1729.65 | 327 / 328 | 98% | 13.60 | 175 / 178 |
adrenal gland | 100% | 3144.07 | 258 / 258 | 95% | 8.84 | 218 / 230 |
liver | 100% | 1748.31 | 226 / 226 | 92% | 8.34 | 373 / 406 |
adipose | 100% | 4334.39 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3428.72 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3087.96 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2869.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.95 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.13 | 1 / 1 |
heart | 98% | 2005.08 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 1805.98 | 887 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 12.95 | 75 / 80 |
lymph node | 0% | 0 | 0 / 0 | 93% | 7.88 | 27 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_1903077 | Biological process | negative regulation of protein localization to plasma membrane |
GO_0099072 | Biological process | regulation of postsynaptic membrane neurotransmitter receptor levels |
GO_0050808 | Biological process | synapse organization |
GO_0051497 | Biological process | negative regulation of stress fiber assembly |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0097444 | Cellular component | spine apparatus |
GO_0030424 | Cellular component | axon |
GO_0048786 | Cellular component | presynaptic active zone |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005829 | Cellular component | cytosol |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0005515 | Molecular function | protein binding |
Gene name | PPFIA1 |
Protein name | Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1) PTPRF interacting protein alpha 1 |
Synonyms | LIP1 |
Description | FUNCTION: May regulate the disassembly of focal adhesions. May localize receptor-like tyrosine phosphatases type 2A at specific sites on the plasma membrane, possibly regulating their interaction with the extracellular environment and their association with substrates. . |
Accessions | ENST00000672873.2 [Q13136-2] ENST00000672559.2 [Q13136-1] ENST00000532504.5 H0YDW2 E9PJZ7 A0A1B0GVT3 ENST00000528853.2 ENST00000648755.1 Q13136 ENST00000533894.5 ENST00000532024.1 ENST00000644155.1 ENST00000526262.5 ENST00000638133.1 H0YDZ8 H0YEK0 E9PID5 H0YF15 H0YEF9 H0YD72 ENST00000526369.3 ENST00000389547.7 [Q13136-2] ENST00000530746.1 E9PPF6 H0YD39 ENST00000530390.5 ENST00000530798.5 A0A2R8Y7R9 A0A3B3ITS2 ENST00000528750.1 ENST00000253925.12 [Q13136-1] |